The United States Clinical Trials Market forecast projects a steady and significant expansion, driven by the integration of technological innovations and the rapid advancement of complex therapeutic modalities. The forecast anticipates a robust Compound Annual Growth Rate (CAGR), primarily fueled by the continued progression of high-cost Phase III trials and the accelerating number of...